SAN CLEMENTE, Calif., July 11, 2017 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its second quarter 2017 earnings release and conference call.
The Company will release its second quarter 2017 results on Wednesday, August 9, 2017 at approximately 4:00 p.m. EDT (1:00 p.m. PDT) and will be conducting a conference call concerning those results at 4:30 p.m. EDT (1:30 p.m. PDT) on Wednesday, August 9, 2017. The call can be accessed at (800) 936-9761, international (408) 774-4587, conference ID 52290938. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in vascular therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT: ICU Medical, Inc. Scott Lamb, Chief Financial Officer (949) 366-4227 ICR, Inc. John Mills, Partner (646) 277-1254


Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
First Western Ship Transits Strait of Hormuz Since Iran War Began
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 



